AKT1 and cancer: Ole’s potential to impact PARPs, the Bax/Bcl2 ratio, the P38 MAPK pathway, HIF-1α, and the Akt and Jnk pathways disrupts cancer’s anti-apoptotic and angiogenic capabilities.